- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02822690
Research Into the Quality of the Dying Phase
Research Into the Quality of the Dying Phase in Hospitals in the Province of Groningen
The aim of this study is to get insight in the quality of life at the end of life and quality of dying for patients died at the hospital in the department Groningen (the Netherlands).
The primary endpoint is the quality of life at the end of life and the secondary endpoint is the quality of dying. Both according a numerical rating scale.
An explorative analysis will be done for differences for the hospitals in Groningen, effect of using the Liverpool care Pathway for the dying, effect of using consultation by the palliative consultation team, effect of using the Hospice@UMCG intervention, correlation with the quality of life at the end of life and quality of dying according to nurses and doctors.
Study Overview
Detailed Description
Three hospitals in the department Groningen (the Netherlands) will participate in this study. When a patient died in one of these hospitals (except the emergency department, child ward and intensive care unit) the bereaved relatives will get an information letter. After about 12 weeks a questionnaire will be sent to the bereaved relative. This questionnaire is developed to evaluate the end of life care at the hospital.
Shortly after the patient died at the hospital, also the nurse and doctor of this patient are requested to fill out a questionnaire.
The questionnaire for the bereaved relatives consists of items, divided in groups: a general part, followed by questions of the last days of life, existing symptoms (physical, psychological, existential and social), the care and treatment and the loss.
The questionnaire for the nurses exists of similar items. Special attention for recognizing the impending dying and problems, care and therapy at the end of life.
In all questionnaires there are also 2 main questions: What is your opinion of the quality of life during the last days of life and What is your opinion of the quality of dying.
In the three hospitals the end of life care is managed at somehow different ways: the use of the Liverpool care Pathway of the dying, the hospice@UMCG intervention and consultation by the palliative team of the hospital.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Groningen, Netherlands, 9713 GZ
- University Medical Center Groningen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients dying in the hospital
Exclusion Criteria:
- patients dying at the child ward, emergency dept. and intensive care dept.
Study Plan
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
University Medical Center Groningen
all patients that died on one of the wards with the exception of children; on several wards the Hospice care will be introduced as an intervention
|
introduction of hospice care facilities on the wards at the UMCG
|
Martini Ziekenhuis
all patients that died on one of the wards with the exception of children
|
|
Ommelander ZorgGroep
all patients that died on one of the wards with the exception of children
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of life questionnaire
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: An KL Reyners, MD/PhD, UMCG
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016pz/1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cessation of Life
-
Société Française d'Anesthésie et de RéanimationRecruitingEnd of Life | Cessation of TreatmentFrance
-
Memorial University of NewfoundlandCompletedSmoking Cessation | Quality of Life | Smoking, TobaccoCanada
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)CompletedQuality of Life | Physical Activity | Tobacco Use CessationUnited States
-
Government College University FaisalabadActive, not recruitingCognitive Behavior Intervention for Psychological Distress, Motivation and Quality of Life Among Individual With Smoking CessationPakistan
-
Truth InitiativeCompletedCessation of Smoking | Use and Dissemination of Smoking Cessation InterventionUnited States
-
SanofiCompletedMaintenance of Smoking CessationUnited States, Canada, Australia
-
Shenyang Northern HospitalNot yet recruitingSmoking Cessation | ACS | Clonal Hematopoiesis of Indeterminate PotentialChina
-
Kübra Arslantürk KhalilCompletedMeaning of Life and Life SatisfactionTurkey
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
Clinical Trials on Hospice care at UMCG
-
Seoul National University HospitalNational Cancer Center, Korea; Chonbuk National University Hospital; Asan Medical... and other collaboratorsCompletedStage IV Lung Cancer | Stage IV Pancreatic Cancer | Stage IV Breast Cancer | Pediatric Brain Tumor | Stage IV Colon Cancer | Stage IV Gastric Cancer | Stage IV Liver Cancer | Malignant Hematologic Neoplasm | Pediatric Solid Tumor | Pediatric Lymphoma | Biliary Cancer Metastatic | Pediatric LeukemiaKorea, Republic of
-
NYU Langone HealthNational Institutes of Health (NIH)CompletedDementiaUnited States
-
NYU Langone HealthNational Institute on Aging (NIA)Active, not recruitingDementiaUnited States
-
Massachusetts General HospitalGordon and Betty Moore FoundationCompletedAdvanced CancerUnited States
-
University of Colorado, DenverNational Institute on Aging (NIA)Completed
-
NYU Langone HealthTerminated
-
Brigham and Women's HospitalRecruiting
-
Massachusetts General HospitalMedically HomeActive, not recruiting
-
Massachusetts General HospitalMedically HomeActive, not recruitingLymphoma | Head and Neck Cancer | Pancreatic Cancer | Rectal Cancer | GastroEsophageal CancerUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)Completed